SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569437
Filing Date
2016-04-29
Accepted
2016-04-29 16:27:11
Documents
6
Period of Report
2016-06-17
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d139420ddef14a.htm DEF 14A 448210
2 GRAPHIC g139420dsp051.jpg GRAPHIC 74811
3 GRAPHIC g139420dsp052.jpg GRAPHIC 163732
4 GRAPHIC g139420g53q27.jpg GRAPHIC 11639
5 GRAPHIC g139420g69k60.jpg GRAPHIC 54390
6 GRAPHIC g139420g95h97.jpg GRAPHIC 9538
  Complete submission text file 0001193125-16-569437.txt   882296
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35935 | Film No.: 161607018
SIC: 2834 Pharmaceutical Preparations